These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 27265898)

  • 21. Clinical significance of circulating tumor cells in patients with locally advanced head and neck squamous cell carcinoma.
    Liu K; Chen N; Wei J; Ma L; Yang S; Zhang X
    Oncol Rep; 2020 May; 43(5):1525-1535. PubMed ID: 32323844
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Liquid biopsy: An emerging prognostic and predictive tool in Head and Neck Squamous Cell Carcinoma (HNSCC). Focus on Circulating Tumor Cells (CTCs).
    Economopoulou P; Kotsantis I; Kyrodimos E; Lianidou ES; Psyrri A
    Oral Oncol; 2017 Nov; 74():83-89. PubMed ID: 29103757
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Neutrophil-to-lymphocyte ratio: Prognostic indicator for head and neck squamous cell carcinoma.
    Rosculet N; Zhou XC; Ha P; Tang M; Levine MA; Neuner G; Califano J
    Head Neck; 2017 Apr; 39(4):662-667. PubMed ID: 28075517
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Evaluation of incidence, significance, and prognostic role of circulating tumor microemboli and transforming growth factor-β receptor I in head and neck cancer.
    Fanelli MF; Oliveira TB; Braun AC; Corassa M; Abdallah EA; Nicolau UR; da Silva Alves V; Garcia D; Calsavara VF; Kowalski LP; Chinen LTD
    Head Neck; 2017 Nov; 39(11):2283-2292. PubMed ID: 28815787
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effect of multimodality treatment on overall survival for patients with metastatic or recurrent HPV-positive head and neck squamous cell carcinoma.
    Deeken JF; Newkirk K; Harter KW; Marshall MB; Banovac F; Johnson L; Wang H; Wang Y; Zhuang T; Jay AK; Berkowitz F; Esposito G; Kallakury B; Davidson B
    Head Neck; 2015 May; 37(5):630-5. PubMed ID: 24616038
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Circulating Tumor Cells as a Prognostic Factor in Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma: The CIRCUTEC Prospective Study.
    Garrel R; Mazel M; Perriard F; Vinches M; Cayrefourcq L; Guigay J; Digue L; Aubry K; Alfonsi M; Delord JP; Lallemant B; Even C; Daurès JP; Landais P; Cupissol D; Alix-Panabières C
    Clin Chem; 2019 Oct; 65(10):1267-1275. PubMed ID: 31387885
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Factors Associated with Recurrence and Regional Adenopathy for Head and Neck Cutaneous Squamous Cell Carcinoma.
    Harris BN; Bayoumi A; Rao S; Moore MG; Farwell DG; Bewley AF
    Otolaryngol Head Neck Surg; 2017 May; 156(5):863-869. PubMed ID: 28322123
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Detection of circulating tumor cells in human peripheral blood using surface-enhanced Raman scattering nanoparticles.
    Wang X; Qian X; Beitler JJ; Chen ZG; Khuri FR; Lewis MM; Shin HJ; Nie S; Shin DM
    Cancer Res; 2011 Mar; 71(5):1526-32. PubMed ID: 21212408
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Concurrent cetuximab and postoperative radiation in resected high-risk squamous cell carcinomas of the head and neck: A single-institution experience.
    Araki D; Redman MW; Martins R; Eaton K; Baik C; Chow L; Goulart B; Lee S; Santana-Davila R; Liao J; Parvathaneni U; Laramore G; Futran N; Mendez E; Bhrany A; Rodriguez CP
    Head Neck; 2016 Sep; 38(9):1318-23. PubMed ID: 27061333
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Transoral laser microsurgery for locally advanced (T3-T4a) supraglottic squamous cell carcinoma: Sixteen years of experience.
    Vilaseca I; Blanch JL; Berenguer J; Grau JJ; Verger E; Muxí Á; Bernal-Sprekelsen M
    Head Neck; 2016 Jul; 38(7):1050-7. PubMed ID: 26872432
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prognostic value of circulating biomarker score in advanced-stage head and neck squamous cell carcinoma.
    Park MJ; Roh JL; Kim SB; Choi SH; Nam SY; Kim SY
    Eur J Cancer; 2018 Mar; 92():69-76. PubMed ID: 29428866
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Measurement of circulating tumor cells in squamous cell carcinoma of the head and neck and patient outcomes.
    Morgan TM; Wang X; Qian X; Switchenko JM; Nie S; Patel KR; Cassidy RJ; Shin DM; Beitler JJ
    Clin Transl Oncol; 2019 Mar; 21(3):342-347. PubMed ID: 30084036
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Oncologic outcomes of patients with positive margins after laser cordectomy for T1 and T2 glottic squamous cell carcinoma.
    Charbonnier Q; Thisse AS; Sleghem L; Mouawad F; Chevalier D; Page C; Mortuaire G
    Head Neck; 2016 Dec; 38(12):1804-1809. PubMed ID: 27248845
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Outcomes after surgery and postoperative radiotherapy for perineural spread of head and neck cutaneous squamous cell carcinoma.
    Warren TA; Panizza B; Porceddu SV; Gandhi M; Patel P; Wood M; Nagle CM; Redmond M
    Head Neck; 2016 Jun; 38(6):824-31. PubMed ID: 25546817
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Postoperative radiotherapy dose requirement in standard combined-modality practice for head and neck squamous cell carcinoma: Analysis of salient surgical and radiotherapy parameters in 2 cohorts.
    Mohanti BK; Thakar A; Kaur J; Bahadur S; Malik M; Gandhi AK; Bhasker S; Sharma A
    Head Neck; 2017 Sep; 39(9):1788-1796. PubMed ID: 28586138
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prognostic relevance of insulin resistance on disease-free survival in head and neck squamous cell carcinomas: Preliminary results.
    Avilés-Jurado FX; Flores JC; Gumà J; Ceperuelo-Mallafré V; Casanova-Marqués R; Gómez D; Vendrell JJ; León X; Vilaseca I; Terra X
    Head Neck; 2017 Dec; 39(12):2501-2511. PubMed ID: 28963801
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Molecular phenotypes of circulating tumor cells and efficacy of nivolumab treatment in patients with head and neck squamous cell carcinoma.
    Tada H; Takahashi H; Kawabata-Iwakawa R; Nagata Y; Uchida M; Shino M; Ida S; Mito I; Matsuyama T; Chikamatsu K
    Sci Rep; 2020 Dec; 10(1):21573. PubMed ID: 33299117
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Insight into the epidemiology of cutaneous squamous cell carcinoma with perineural spread.
    Warren TA; Whiteman DC; Porceddu SV; Panizza BJ
    Head Neck; 2016 Sep; 38(9):1416-20. PubMed ID: 27043827
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Inferior outcomes in immunosuppressed patients with high-risk cutaneous squamous cell carcinoma of the head and neck treated with surgery and radiation therapy.
    Manyam BV; Gastman B; Zhang AY; Reddy CA; Burkey BB; Scharpf J; Alam DS; Fritz MA; Vidimos AT; Koyfman SA
    J Am Acad Dermatol; 2015 Aug; 73(2):221-7. PubMed ID: 26028524
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prognostic value of albumin in patients with head and neck cancer.
    Danan D; Shonka DC; Selman Y; Chow Z; Smolkin ME; Jameson MJ
    Laryngoscope; 2016 Jul; 126(7):1567-71. PubMed ID: 26864349
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.